CTI completes sale of 15.

CTI completes sale of 15,000 shares to Quogue Capital Cell Therapeutics, Inc levitra . today announced the closing of its previously announced sale of 15,000 shares of its Series 18 Preferred Stock right to Quogue Capital LLC and an affiliate of Perceptive Advisors LLC in a authorized direct offering conducted without an underwriter or positioning agent for gross proceeds of approximately $15 million . The net arises from the Supplying, after deducting estimated offering expenses, were around $14.8 million. Related StoriesJumping genes: a marker for early malignancy analysis? An interview with Dr KazazianLiposomal sizing and the Coulter basic principle: an interview with Professor Melvin E.

Other entries from category "therapy":

Random entries